VALLEY COTTAGE, New York, June 27, 2017 /PRNewswire/ --
A new report from Future Market Insights reveals thatglobal atopic dermatitis treatment market revenue is set to expand at a CAGR of 12.8% over the forecast period (2017-2027). In recent years, the prevalence of atopic dermatitis has increased to a great extent, leading to higher demand for its treatment.
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
The report, titled "Atopic Dermatitis Treatment Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027" has also analysed the market by splitting it into regional segments. The dominance of North America on the global atopic dermatitis treatment is expected to remain throughout the assessment period. In 2016, the region's dermatitis treatment market accounted for a revenue share of 30%. The market in the region is anticipated to witness a CAGR of 16.0% to reach a valuation of US$ 10,384 Mn over 2027. Meanwhile, the market is Western Europe will maintain its second position behind North America. Pharma companies in Europe are concentrating on expanding their product portfolio by acquiring smaller companies specialised in dermatology portfolios. The report also projects a considerable growth of the atopic dermatitis treatment market in Asia pacific excluding Japan (APEJ) over the next couple of years.
Request a Sample Report with Table of Contents and Figures: http://www.futuremarketinsights.com/reports/sample/rep-gb-3097
Additional Highlight of the Report Include:
Preview Analysis on Global Atopic Dermatitis Treatment Market Taxonomy By Drug Type - Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines, Emollients; By Mode of Administration - Topical, Oral, Injectable; By Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Mail Order Pharmacies, Dermatology Clinics: http://www.futuremarketinsights.com/reports/atopic-dermatitis-treatment-market
Some of the leading pharmaceutical companies that have an active participation in the global atopic dermatitis treatment market include: Sanofi SA, Galderma SA, Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals, Astellas Pharma Inc., Anacor Pharmaceutical Inc., Regeneron Pharmaceuticals, Aqua Pharmaceuticals (An Almirall Company), Pfizer, Dow Pharm, Connetics Corporation, Fujisawa Healthcare, Encore Dermatology, LEO Pharma, Velite Pharmaceutical, Biofrontera AG.
Many of these market players are implementing strategies such as merger and acquisition in order to enhance their product portfolio. At the same time, increasing numbers collaborations among market players and medical research institutes are leading to new product development.
More from FMI's Cutting-edge Intelligence:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44-(0)20-7692-8790 Sales: [email protected] Press Office: [email protected]
FMI Blog: http://www.fmiblog.com/
SOURCE Future Market Insights
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...View All